Abiomed
ABMD
#1251
Rank
NZ$31.40 B
Marketcap
NZ$696.50
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

EPS for Abiomed (ABMD)

EPS in 2022 (TTM): NZ$9.47

According to Abiomed's latest financial reports the company's current EPS (TTM) is NZ$10.75. In 2021 the company made an earnings per share (EPS) of NZ$5.36 a decrease over its 2020 EPS that were of NZ$8.13.

EPS history for Abiomed from 2013 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ$9.4776.83%
2021NZ$5.36-34.16%
2020NZ$8.13-18.05%
2019NZ$9.939.48%
2018NZ$9.07141.95%
2017NZ$3.7581.42%
2016NZ$2.07-62.83%
2015NZ$5.56575.56%
2014NZ$0.82125%
2013NZ$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Boston Scientific
BSX
NZ$4.33-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
NZ-$42.56-495.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ$0.55-94.90%๐Ÿ‡บ๐Ÿ‡ธ USA